{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:29:09Z","timestamp":1791192549579,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.ajic.2006.05.226","type":"journal-article","created":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T14:20:53Z","timestamp":1153491653000},"page":"S29-S37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"S","title":["Resistance in nonfermenting gram-negative bacteria: Multidrug resistance to the maximum"],"prefix":"10.1016","volume":"34","author":[{"suffix":"Jr.","given":"John E.","family":"McGowan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2006.05.226_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/CMR.17.1.57-71.2004","article-title":"Infection control in cystic fibrosis","volume":"17","author":"Saiman","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ajic.2006.05.226_bib2","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/thx.2003.017210","article-title":"Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis","volume":"59","author":"Jones","year":"2004","journal-title":"Thorax"},{"issue":"suppl 1","key":"10.1016\/j.ajic.2006.05.226_bib3","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1086\/514912","article-title":"Clinical problems posed by multiresistant nonfermenting gram-negative pathogens","volume":"27","author":"Quinn","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/qjmed\/hcg031","article-title":"Bacteraemia in adults due to glucose non-fermentative gram-negative bacilli other than P. aeruginosa","volume":"96","author":"Vidal","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.ajic.2006.05.226_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3810\/pgm.2005.01.1571","article-title":"Severe Pseudomonas aeruginosa infections. Tackling the conundrum of drug resistance","volume":"117","author":"Hauser","year":"2005","journal-title":"Postgrad Med"},{"key":"10.1016\/j.ajic.2006.05.226_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1054\/drup.2000.0152","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment","volume":"3","author":"Hancock","year":"2000","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ajic.2006.05.226_bib7","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1086\/432803","article-title":"Overview of nosocomial infections caused by gram-negative bacilli","volume":"41","author":"Gaynes","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1086\/375821","article-title":"Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City","volume":"37","author":"Quale","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib9","first-page":"1063","article-title":"Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002\u20132004","volume":"53","author":"Centers for Disease Control and Prevention (CDC)","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2006.05.226_bib10","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1128\/AAC.47.5.1681-1688.2003","article-title":"Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001","volume":"47","author":"Karlowsky","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijantimicag.2003.12.019","article-title":"Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)","volume":"24","author":"Streit","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajic.2006.05.226_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0732-8893(02)00540-0","article-title":"Pathogens of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000)","volume":"45","author":"Hoban","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0732-8893(02)00543-6","article-title":"Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000)","volume":"45","author":"Rennie","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0272-5231(05)70143-X","article-title":"Antimicrobial resistance in intensive care units","volume":"20","author":"Fridkin","year":"1999","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ajic.2006.05.226_bib15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004","volume":"32","author":"National Nosocomial Infections Surveillance System","year":"2004","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2006.05.226_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10096-005-1294-x","article-title":"Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B","volume":"24","author":"Bratu","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jac\/dkg270","article-title":"Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997\u20132001)","volume":"52","author":"Andrade","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 2","key":"10.1016\/j.ajic.2006.05.226_bib18","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1086\/426188","article-title":"Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001\u20132003 Tracking Resistance in the United States Today surveillance studies","volume":"40","author":"Karlowsky","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/jac\/dki153","article-title":"Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B","volume":"55","author":"Landman","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib20","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/339488","article-title":"Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms","volume":"34","author":"Trouillet","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"suppl 3","key":"10.1016\/j.ajic.2006.05.226_bib21","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1086\/321840","article-title":"Minimizing potential resistance: the molecular view","volume":"33","author":"Courvalin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1128\/AAC.49.2.565-570.2005","article-title":"Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa","volume":"49","author":"Kriengkauykiat","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/jac\/48.4.553","article-title":"In vivo selection of a target\/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy","volume":"48","author":"Le Thomas","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1348-0421.2002.tb02711.x","article-title":"High-level fluoroquinolone resistance in Pseudomonas aeruginosa due to interplay of the MexAB-OprM efflux pump and the DNA gyrase mutation","volume":"46","author":"Nakajima","year":"2002","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.ajic.2006.05.226_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0924-8579(03)00009-8","article-title":"Mutations in GyrA, ParC, MexR, and NfxB in clinical isolates of Pseudomonas aeruginosa","volume":"21","author":"Higgins","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajic.2006.05.226_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/jac\/48.4.549","article-title":"Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia","volume":"48","author":"Zhang","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0025-7125(05)70303-5","article-title":"Antipseudomonal antibiotics","volume":"85","author":"Giamarellou","year":"2001","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.ajic.2006.05.226_bib28","doi-asserted-by":"crossref","unstructured":"GF Weldhagen, L Poirel, P Nordmann. Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother 2003;47:2385-92.","DOI":"10.1128\/AAC.47.8.2385-2392.2003"},{"key":"10.1016\/j.ajic.2006.05.226_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.diagmicrobio.2004.07.003","article-title":"Emerging epidemic of metallo-beta-lactamase-mediated resistances","volume":"51","author":"Jones","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"suppl 4","key":"10.1016\/j.ajic.2006.05.226_bib30","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1086\/430790","article-title":"Emerging metallo-beta-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance program","volume":"41","author":"Fritsche","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/AAC.35.1.147","article-title":"Transferable imipenem resistance in Pseudomonas aeruginosa","volume":"35","author":"Watanabe","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib32","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jac\/dkh398","article-title":"Emergence of IMP-4 metallo-beta-lactamase in a clinical isolate from Australia","volume":"54","author":"Peleg","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.diagmicrobio.2004.05.002","article-title":"Metallo-beta-lactamase-producing gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp","volume":"50","author":"Lee","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib34","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/AAC.45.8.2224-2228.2001","article-title":"Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme","volume":"45","author":"Yan","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","article-title":"Aminoglycoside resistance in Pseudomonas aeruginosa","volume":"49","author":"Poole","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib36","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/375081","article-title":"The impact of antimicrobial resistance on health and economic outcomes","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib37","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","article-title":"Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome","volume":"49","author":"Kang","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib38","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archinte.165.12.1375","article-title":"Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: variability by site of infection","volume":"165","author":"Hyle","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajic.2006.05.226_bib39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ajic.2006.05.226_bib40","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ajic.2006.05.226_bib41","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1128\/AAC.49.4.1306-1311.2005","article-title":"Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment","volume":"49","author":"Micek","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jac\/dki026","article-title":"Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes","volume":"55","author":"Hsu","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib43","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/cc3020","article-title":"Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis","volume":"9","author":"Michalopoulos","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.ajic.2006.05.226_bib44","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/AAC.47.8.2659-2662.2003","article-title":"Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria","volume":"47","author":"Ouderkirk","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib45","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1128\/JCM.43.9.4916-4917.2005","article-title":"Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin","volume":"43","author":"Katragkou","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.226_bib46","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3201\/eid0702.010228","article-title":"Economic impact of antimicrobial resistance","volume":"7","author":"McGowan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib47","series-title":"Institute of Medicine. Antimicrobial Drug Resistance: Issues and Options. Institute of Medicine Workshop Report","author":"Harrison","year":"1998"},{"key":"10.1016\/j.ajic.2006.05.226_bib48","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ajic.2004.02.008","article-title":"Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital","volume":"32","author":"Wilson","year":"2004","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2006.05.226_bib49","unstructured":"Jones RN, Fritsche TR, for the CAP-MRC Members. Accuracy for antibacterial and antifungal susceptibility tests: report from the College of American Pathologists (CAP) Microbiology Proficiency Survey Program for 2004\u20132005. Presented at the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2005 Dec 16-19; Washington, DC; 2005."},{"key":"10.1016\/j.ajic.2006.05.226_bib50","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1128\/JCM.42.11.5102-5108.2004","article-title":"Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods","volume":"42","author":"Swenson","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.226_bib51","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1345\/aph.1D592","article-title":"Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians","volume":"38","author":"Jain","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ajic.2006.05.226_bib52","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1086\/502311","article-title":"Emergence of resistance in Pseudomonas aeruginosa and Acinetobacter species after the use of antimicrobials for burned patients","volume":"25","author":"Ferreira","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2006.05.226_bib53","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3201\/eid1106.050167","article-title":"Antimicrobial resistance determinants and future control","volume":"11","author":"Harbarth","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib54","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.289.7.885","article-title":"Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use","volume":"289","author":"Neuhauser","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ajic.2006.05.226_bib55","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-129-3-199808010-00003","article-title":"Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology","volume":"129","author":"Villers","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajic.2006.05.226_bib56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s15010-005-4021-8","article-title":"Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms","volume":"33","author":"Leroy","year":"2005","journal-title":"Infection"},{"key":"10.1016\/j.ajic.2006.05.226_bib57","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/381550","article-title":"Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity","volume":"38","author":"Paramythiotou","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib58","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0891-5520(05)70357-3","article-title":"Control of antimicrobial resistance in the health care system","volume":"11","author":"McGowan","year":"1997","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ajic.2006.05.226_bib59","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1128\/JCM.43.7.3129-3135.2005","article-title":"Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory","volume":"43","author":"Pitout","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2006.05.226_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.48.1.329-332.2004","article-title":"blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States","volume":"48","author":"Toleman","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2006.05.226_bib61","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1086\/420937","article-title":"Trends in antimicrobial drug development: implications for the future","volume":"38","author":"Spellberg","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.05.226_bib62","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/382363","article-title":"Minimizing antimicrobial resistance: the key role of the infectious diseases physician","volume":"38","author":"McGowan","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655306007656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655306007656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:28:42Z","timestamp":1759296522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655306007656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0196655306007656"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2006.05.226","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance in nonfermenting gram-negative bacteria: Multidrug resistance to the maximum","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2006.05.226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Association for Professionals in Infection Control and Epidemiology, Inc. and Elsevier, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}